Abstract
The management of lupus nephritis in pregnancy presents a diagnostic and therapeutic challenge for providers. Pregnancy creates a series of physiologic changes in the immune system and kidney that may result in an increased risk of disease flare and adverse maternal and fetal outcomes, such as preeclampsia, fetal loss, and preterm delivery. Conception should be delayed until disease is in remission to ensure the best pregnancy outcomes. Maternal disease activity and fetal well-being should be monitored closely by an interdisciplinary team, including obstetricians, rheumatologists, and nephrologists throughout pregnancy. Careful attention must be paid to the dosing and potential teratogenicity of medications.
Original language | English (US) |
---|---|
Pages (from-to) | 487-499 |
Number of pages | 13 |
Journal | Seminars in nephrology |
Volume | 35 |
Issue number | 5 |
DOIs | |
State | Published - 2015 |
Keywords
- Anti-inflammatory agents/therapeutic use
- Lupus nephritis
- Preeclampsia
- Pregnancy
- Pregnancy complications
- Systemic lupus erythematosus
ASJC Scopus subject areas
- Nephrology